×
About 8,412 results

AllMedicine All Center

Research & Reviews  3,929 results

Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP...
https://doi.org/10.1016/j.gie.2017.09.021
Gastrointestinal Endoscopy; Park CH, Jung JH et. al.

Oct 1st, 2017 - The optimal timing of refeeding after ERCP is unknown. Some practices keep the patient fasting for 24 hours after ERCP, whereas others resume feeding earlier. We aimed to evaluate the risk of post-ERCP pancreatitis (PEP) in patients who initiate e...

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation...
https://doi.org/10.1136/annrheumdis-2016-210872
Annals of the Rheumatic Diseases; Stamp LK, Chapman PT et. al.

Mar 20th, 2017 - To determine the efficacy and safety of allopurinol dose escalation using a treat-to-target serum urate (SU) approach. A randomised, controlled, parallel-group, comparative clinical trial was undertaken. People with gout receiving at least creatin...

Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment.
https://doi.org/10.1016/j.jacc.2019.07.070
Journal of the American College of Cardiology; Eikelboom JW, van Ryn J et. al.

Oct 3rd, 2019 - Dabigatran and idarucizumab, its reversal agent, are renally cleared. The purpose of this study was to determine the extent of reversal and outcomes according to baseline renal function in dabigatran-treated nondialysis patients receiving idaruciz...

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
https://doi.org/10.1056/NEJMoa1710030
The New England Journal of Medicine; Torres VE, Chapman AB et. al.

Nov 6th, 2017 - In a previous trial involving patients with early autosomal dominant polycystic kidney disease (ADPKD; estimated creatinine clearance, ≥60 ml per minute), the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume an...

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegra...
https://doi.org/10.1016/S0140-6736(15)60616-X
Lancet (London, England); Sax PE, Wohl D et. al.

Apr 21st, 2015 - Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide is a novel tenofovir prodrug with a 90% reduction in plasma tenofovir concentrations. Tenofovir alafenamide...

see more →

Guidelines  2 results

KDIGO 2012 Clinical Practice Guideline CKD classification rules out creatinine clearanc...
https://doi.org/10.1016/j.clinbiochem.2015.07.030
Clinical Biochemistry; Ognibene A, Grandi G et. al.

Aug 1st, 2015 - The recent guideline for the evaluation and management of Chronic Kidney Disease recommends assessing GFR employing equations based on serum creatinine; despite this, creatinine clearance 24-hour urine collection is used routinely in many settings...

Cystic Fibrosis Foundation practice guidelines for the management of infants with cysti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326077
The Journal of Pediatrics; , Borowitz D et. al.

Feb 5th, 2010 - Through early detection, newborn screening (NBS)(1) for cystic fibrosis (CF) offers the opportunity for early intervention and improved outcomes. NBS programs screen for hypertrypsinogenemia, and most also identify mutations in the CF transmembran...

see more →

Drugs  49 results see all →

Clinicaltrials.gov  4,191 results

Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP...
https://doi.org/10.1016/j.gie.2017.09.021
Gastrointestinal Endoscopy; Park CH, Jung JH et. al.

Oct 1st, 2017 - The optimal timing of refeeding after ERCP is unknown. Some practices keep the patient fasting for 24 hours after ERCP, whereas others resume feeding earlier. We aimed to evaluate the risk of post-ERCP pancreatitis (PEP) in patients who initiate e...

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation...
https://doi.org/10.1136/annrheumdis-2016-210872
Annals of the Rheumatic Diseases; Stamp LK, Chapman PT et. al.

Mar 20th, 2017 - To determine the efficacy and safety of allopurinol dose escalation using a treat-to-target serum urate (SU) approach. A randomised, controlled, parallel-group, comparative clinical trial was undertaken. People with gout receiving at least creatin...

Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment.
https://doi.org/10.1016/j.jacc.2019.07.070
Journal of the American College of Cardiology; Eikelboom JW, van Ryn J et. al.

Oct 3rd, 2019 - Dabigatran and idarucizumab, its reversal agent, are renally cleared. The purpose of this study was to determine the extent of reversal and outcomes according to baseline renal function in dabigatran-treated nondialysis patients receiving idaruciz...

CETYLEV® (acetylcysteine)
http://cetylev.com/

Hypersensitivity reactions, including generalized urticaria have been observed in patients receiving oral acetylcysteine overdose. If hypersensitivity reactions occur, Cetylev should be discontinued unless it is deemed essential for patient manage...

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
https://doi.org/10.1056/NEJMoa1710030
The New England Journal of Medicine; Torres VE, Chapman AB et. al.

Nov 6th, 2017 - In a previous trial involving patients with early autosomal dominant polycystic kidney disease (ADPKD; estimated creatinine clearance, ≥60 ml per minute), the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume an...

see more →

News  239 results

Valproic acid-induced hyperammonemic encephalopathy
https://www.mdedge.com/psychiatry/article/214883/bipolar-disorder/valproic-acid-induced-hyperammonemic-encephalopathy/page/0/1?channel=36771

Jan 2nd, 2020 - Diagnosis and management. If a patient receiving VPA is experiencing nausea, fatigue, or somnolence, it is important to check the patient’s ammonia level (normal range: 11 to 32 µmol/L) and VPA total levels (therapeutic range: 50 to 125 µg/mL).

Proteinuria and Albuminuria: What’s the Difference?
https://www.mdedge.com/clinicianreviews/article/210146/nephrology/proteinuria-and-albuminuria-whats-difference?channel=37532
Cynthia A. Smith, DNP, CNN-NP, FNP-BC, APRN, FNKF

Oct 15th, 2019 - Q)What exactly is the difference between the protein-to-creatinine ratio and the microalbumin in the lab report? How do they compare? For the non-nephrology provider, the options for evaluating urine protein or albumin can seem confusing. The firs.

Cath Lab Recap: 'Ultra-Low' Contrast for PCI; Stroke Tx Reperfusion Overestimated
https://www.medpagetoday.com/cardiology/pci/74854

Aug 29th, 2018 - Percutaneous coronary intervention can be performed with "ultra-low" contrast volume -- less than or equal to the patient's estimated creatinine clearance -- when the individual is at high risk of acute kidney injury. (Catheterization and Cardiova...

How to choose between highly effective HBV therapies
https://www.mdedge.com/familymedicine/article/166121/infectious-diseases/how-choose-between-highly-effective-hbv-therapies/page/0/3
Internal Medicine News;

May 19th, 2018 - Conversely, entecavir, an older and less expensive drug than TAF, deserves priority in a patient with no prior exposure to a nucleoside, no HIV coinfection, or in an individual with a creatinine clearance below 15 mL/min after dose adjustment. TAF.

Management of Patients with HIV and Hepatitis B Coinfection
https://www.mdedge.com/jcomjournal/article/149688/infectious-diseases/management-patients-hiv-and-hepatitis-b-coinfection/page/0/3

Oct 18th, 2017 - • When should HBV treatment be started in patients with coinfection? An ART regimen containing TDF (creatinine clearance > 50 mL/min) or TAF (creatinine clearance > 30 mL/min) with lamivudine or emtricitabine should be used in all HIV/HBV patients.

see more →

Patient Education  2 results see all →